Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012)

Bausch Health Companies (BHC) reported Change in Account Payables of -$9.9 million for Q1 2012, up 73.76% on a YoY basis from -$5.7 million in Q2 2011, and up 35.91% sequentially from -$15.5 million in Q4 2011.

Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012) Analysis & Trends

Bausch Health Companies (BHC) has 4 years of Change in Account Payables data on file, last reported at -$9.9 million in Q1 2012.

  • For the quarter ending Q1 2012, Change in Account Payables rose 73.76% year-over-year to -$9.9 million; the trailing twelve-month figure through Mar 2012 stood at $18.9 million (up 122.46% YoY), and the FY2011 full-year result was -$9.0 million, up 88.2% from the prior year.
  • Change in Account Payables climbed to -$9.9 million in Q1 2012, from -$15.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $34.1 million in Q4 2009 to a low of -$68.1 million in Q4 2010.
  • A 4-year average of -$4.0 million and a median of $2.8 million in 2009 frame the typical range for Change in Account Payables.
  • Across the five-year window, Change in Account Payables slumped 299.6% in 2010 and jumped 4958.13% in 2011, its largest moves.
  • Tracing BHC's Change in Account Payables over 4 years: stood at $34.1 million in 2009, then tumbled by 299.6% to -$68.1 million in 2010, then surged by 77.26% to -$15.5 million in 2011, then surged by 35.91% to -$9.9 million in 2012.
  • Business Quant data shows BHC's Change in Account Payables at -$9.9 million in Q1 2012, -$15.5 million in Q4 2011, and $16.8 million in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2012 -9.92 Mn
Mar 31, 2012 -9.92 Mn
Dec 31, 2011 -15.48 Mn
Dec 31, 2011 -15.48 Mn
Sep 30, 2011 16.81 Mn
Sep 30, 2011 16.81 Mn
Jun 30, 2011 27.50 Mn
Jun 30, 2011 27.50 Mn
Mar 31, 2011 -37.81 Mn
Mar 31, 2011 -37.81 Mn
Dec 31, 2010 -68.08 Mn
Dec 31, 2010 -68.08 Mn
Sep 30, 2010 22.28 Mn
Sep 30, 2010 22.28 Mn
Jun 30, 2010 -566,000.00
Jun 30, 2010 -566,000.00
Mar 31, 2010 -29.73 Mn
Mar 31, 2010 -29.73 Mn
Dec 31, 2009 34.11 Mn
Dec 31, 2009 34.11 Mn